Does AMBRISENTAN Cause Pulmonary arterial hypertension? 1,965 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,965 reports of Pulmonary arterial hypertension have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 2.3% of all adverse event reports for AMBRISENTAN.
1,965
Reports of Pulmonary arterial hypertension with AMBRISENTAN
2.3%
of all AMBRISENTAN reports
432
Deaths
1,266
Hospitalizations
How Dangerous Is Pulmonary arterial hypertension From AMBRISENTAN?
Of the 1,965 reports, 432 (22.0%) resulted in death, 1,266 (64.4%) required hospitalization, and 41 (2.1%) were considered life-threatening.
Is Pulmonary arterial hypertension Listed in the Official Label?
Yes, Pulmonary arterial hypertension is listed as a known adverse reaction in the official FDA drug label for AMBRISENTAN.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Pulmonary arterial hypertension?
TREPROSTINIL (3,240)
MACITENTAN (2,390)
SELEXIPAG (1,387)
EPOPROSTENOL (1,055)
BOSENTAN (778)
TADALAFIL (680)
SILDENAFIL (487)
RIOCIGUAT (436)
ILOPROST (284)
BOSENTAN\BOSENTAN (245)
Which AMBRISENTAN Alternatives Have Lower Pulmonary arterial hypertension Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE